The IGF‐II overexpression is the most widespread molecular event that occurs in 90% of the ACC patients and causes an autocrine mitogenic effect through activation of different signalling pathways mediated by IGF1R.6 This evidence concerns the gene IGF2 and adrenal cortex carcinoma.